List of insiders holdings for Histogen Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | ADVENT VENTURE PARTNERS LLP 10% Owner | 2014-02-13 14:01:02 | 2,243,503 0 | 2,243,503 | Form 13G |
| 2 | Perret Marc Olivier Director 10% Owner | 2013-08-01 19:18:10 | 30,000 1,504,062 | 1,534,062 | Form 4 |
| 3 | COOPERATIVE GILDE HEALTHCARE II U.A. 10% Owner | 2013-08-01 19:10:35 | 1,504,062 0 | 1,504,062 | Form 4 |
| 4 | KLINGENSTEIN PAUL H Director | 2014-02-25 17:37:58 | 40,644 1,404,535 | 1,445,179 | Form 4 |
| 5 | EVNIN LUKE Foley Todd GADICKE ANSBERT KAILIAN VAUGHN M Vander Vort John 10% Owner | 2013-08-01 14:19:53 | 0 1,241,016 | 1,241,016 | Form 4 |
| 6 | Mento Steven J President and CEO | 2023-03-14 16:32:12 | 213,587 0 | 213,587 | Form 4 |
| 7 | Hagerty David T EVP, Clinical Development | 2019-02-11 16:15:20 | 175,000 0 | 175,000 | Form 4 |
| 8 | Latterich Martin SVP, Technical Operations | 2022-02-22 18:18:41 | 134,900 0 | 134,900 | Form 4 |
| 9 | RIPLEY DANIEL L. SVP, Bus Dev, P&A Mgmt | 2019-02-11 16:19:31 | 100,000 32,431 | 132,431 | Form 4 |
| 10 | Smith Edward F III SVP, Reg Affairs and QA | 2019-02-11 16:20:30 | 110,875 0 | 110,875 | Form 4 |
| 11 | Knudson Susan A. COO and CFO | 2023-03-14 16:33:04 | 106,793 0 | 106,793 | Form 4 |
| 12 | Spada Alfred P. See Remarks | 2023-02-27 16:18:17 | 106,793 0 | 106,793 | Form 4 |
| 13 | Daniels Moya See Remarks | 2021-01-15 16:11:52 | 100,000 0 | 100,000 | Form 4 |
| 14 | Naughton Gail K See Remarks | 2021-01-15 16:14:23 | 95,000 0 | 95,000 | Form 4 |
| 15 | VANDERTIE MICHELLE L Vice President, Finance | 2019-08-01 16:13:44 | 86,375 0 | 86,375 | Form 4 |
| 16 | Reyes Joyce See Remarks | 2023-04-28 18:56:26 | 64,076 0 | 64,076 | Form 4/A |
| 17 | Cashion Charles SVP, Finance, CFO and Sec. | 2017-02-01 16:21:33 | 57,500 0 | 57,500 | Form 4 |
| 18 | BURGESS GARY C. Sr. VP, Clin. Res. & CMO | 2014-02-11 16:49:51 | 50,000 0 | 50,000 | Form 4 |
| 19 | HALE DAVID F Director | 2019-07-01 16:31:01 | 45,000 0 | 45,000 | Form 4 |
| 20 | Pascoe Richard W President, CEO & Director | 2021-03-30 18:28:01 | 30,000 0 | 30,000 | Form 4 |
| 21 | Scott Kathleen D. Director | 2019-11-19 16:10:50 | 30,000 0 | 30,000 | Form 4 |
| 22 | Klassen Preston Director | 2019-07-01 16:33:36 | 20,000 0 | 20,000 | Form 4 |
| 23 | Malik Shahzad Director 10% Owner | 2016-06-27 16:23:40 | 20,000 0 | 20,000 | Form 4 |
| 24 | Zhang Yizhuo Director | 2020-10-09 16:15:57 | 20,000 0 | 20,000 | Form 4 |
| 25 | Chang Stephen Director | 2020-10-09 16:05:33 | 20,000 0 | 20,000 | Form 4 |
| 26 | Scopa James Paul Director | 2018-06-25 16:07:41 | 20,000 0 | 20,000 | Form 4 |
| 27 | Van Wart Harold Director | 2019-07-01 16:34:48 | 20,000 0 | 20,000 | Form 4 |
| 28 | LARUE WILLIAM R Director | 2019-07-01 16:34:13 | 20,000 0 | 20,000 | Form 4 |
| 29 | Marshall Keith W EVP, COO & CFO | 2020-05-27 06:09:23 | 19,885 0 | 19,885 | Form 4 |
| 30 | LACASSE LOUIS P Director | 2015-06-15 16:09:34 | 15,000 0 | 15,000 | Form 4 |
| 31 | Crean David Hugh Director | 2023-06-21 16:07:29 | 6,835 0 | 6,835 | Form 4 |
| 32 | Fuhrmann Rochelle Director | 2023-06-21 16:08:04 | 6,835 0 | 6,835 | Form 4 |
| 33 | Jackson Jonathan Director | 2023-06-21 16:08:39 | 6,835 0 | 6,835 | Form 4 |
| 34 | KISNER DANIEL L Director | 2023-06-21 16:09:19 | 6,835 0 | 6,835 | Form 4 |
| 35 | Satz Brian Director | 2023-06-21 16:10:02 | 6,835 0 | 6,835 | Form 4 |
| 36 | Windham-Bannister Susan Richards Director | 2023-06-21 16:11:05 | 6,835 0 | 6,835 | Form 4 |
| 37 | Aberdare GP III L.L.C. Aberdare Ventures III LP Aberdare Partners III LP Former 10% Owner | 2017-02-13 06:05:32 | 5,251 0 | 5,251 | Form 13G |
| 38 | MPM BioVentures IV QP LP MPM BioVentures IV GP LLC MPM BioVentures IV LLC MPM Asset Management Investors BV4 LLC MPM BioVentures IV GmbH & Co. Beteiligungs KG MPM BIOVENTURES V GP LLC MPM BIOVENTURES V LLC MPM BIOVENTURES V L.P. MPM ASSET MANAGEMENT INVESTORS BV5 LLC 10% Owner | 2020-02-05 14:11:03 | 0 0 | 0 | Form 13G |